about
The role of histamine in neurogenic inflammationPain care for patients with epidermolysis bullosa: best care practice guidelines.SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivoEffects of a skin neuropeptide (substance p) on cutaneous microflora.Lewandowsky's Rosaceiform Eruption: a Form of Cutaneous Tuberculosis Confirmed by PCR in Two Patients.Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations.A histamine-independent itch pathway is required for allergic ocular itch.Maternal serum but not breast milk IL-5, IL-6, and IL-13 immune markers are associated with scratching among infants.TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis.Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practicesDiagnostics and new developments in the treatment of ocular allergies.Histamine H4 receptor ligands and their potential therapeutic applications: an update.Medical treatment of pruritus.Investigational drugs for pruritus.Novel investigational therapies for atopic dermatitis.Allergic host defences.Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models.Irritable bowel syndrome in patients with chronic pruritus of undetermined origin.B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid.S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version.S2k-Leitlinie zur Diagnostik und Therapie des chronischen Pruritus - Update - Kurzversion.Nerve growth factor interactions with mast cells.Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis
P2860
Q26993211-2ABF18FA-F404-422B-B848-6552AF2AE931Q30590549-08BBBD26-72E3-49C1-B971-49BADF5D5DCFQ30850558-E435EE06-D4F2-4882-96F9-C3EDE75E0E9DQ35046639-F81D0F7E-8273-4604-9D1F-752083DF8D6DQ35217919-E19384A8-5438-4EEF-A48F-5BB2D40A0B71Q36418910-CCD65716-3175-4B75-A379-6A8C431FACBEQ36784545-C9DCF1EB-FDF7-4DAA-85BB-9F21FA6E1AA1Q36929815-D46D8C45-C20B-417C-AF7C-BE8978A025F6Q37118783-E1850B2F-6E6D-4970-8941-C894C7761156Q37648132-C52C049D-51C8-4C0C-9124-CB6F91FCAB21Q37989819-F1EFB6AE-9C24-4EF9-8269-648EE14BD804Q37990004-FC44CCEE-A8A5-4EA2-A4B3-650A040FCA26Q38032599-0D93B75B-D21D-47F7-A755-372B699ACA78Q38118383-FE6FB568-1AA9-4738-ABB4-9C83C4FE904AQ38247119-B2185B4A-9456-450B-A89D-563F971AB1A3Q41190858-F874010C-EBE1-451B-B1E0-E9554677D272Q42138353-3950719D-358B-4F07-B488-C98FB18BE5B1Q43669836-A3E18357-BF6F-45DB-894C-5E373BC77E6DQ46484331-6D4C710F-602F-47A6-B7A6-5B41E171C179Q47759075-1DEF50C1-6439-448D-B75F-3FA56B69204DQ52836710-7022A3A5-AD22-4006-9C42-971E78EA0ED7Q53060410-91FFE279-749C-4C9D-81C8-72405A8C23BEQ56984161-FEDD6E6A-0684-4B59-8CED-1DDABA221EBA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of itch and new treatments.
@en
Pathophysiology of itch and new treatments.
@nl
type
label
Pathophysiology of itch and new treatments.
@en
Pathophysiology of itch and new treatments.
@nl
prefLabel
Pathophysiology of itch and new treatments.
@en
Pathophysiology of itch and new treatments.
@nl
P1476
Pathophysiology of itch and new treatments.
@en
P2093
Ulrike Raap
P304
P356
10.1097/ACI.0B013E32834A41C2
P577
2011-10-01T00:00:00Z